US Patent Issued to ABDERA THERAPEUTICS on July 1 for "Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex" (Canadian, American Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,675, issued on July 1, was assigned to ABDERA THERAPEUTICS INC. (South San Francisco, Calif.).

"Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex" was invented by Michael J. Abrams (Custer, Wash.), Emma Jane Cummins (Vancouver, Canada), Adam Daniel Judge (Bainbridge Island, Wash.), Alexander Laurence Mandel (Vancouver, Canada) and Raja Solomon Viswas (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cance...